Purification and Characterization of Pyridoxine 5′-Phosphate

Total Page:16

File Type:pdf, Size:1020Kb

Purification and Characterization of Pyridoxine 5′-Phosphate Biosci. Biotechnol. Biochem., 69 (12), 2277–2284, 2005 Purification and Characterization of Pyridoxine 50-Phosphate Phosphatase from Sinorhizobium meliloti y Masaaki TAZOE, ,* Keiko ICHIKAWA,** and Tatsuo HOSHINO* Department of Applied Microbiology, Nippon Roche Research Center, Kamakura, Kanagawa 247-8530, Japan Received April 15, 2005; Accepted July 29, 2005 Here we report the purification and biochemical 1-deoxy-D-xylulose 5-phosphate. The former is synthe- characterization of a pyridoxine 50-phosphate phospha- sized from D-erythrose 4-phosphate in three reaction tase involved in the biosynthesis of pyridoxine in steps catalyzed by Epd, PdxB, and SerC (PdxF) proteins Sinorhizobium meliloti. The phosphatase was localized in that order.4–7) The latter is formed from pyruvate and in the cytoplasm and purified to electrophoretic homo- D-glyceraldehyde 3-phosphate by 1-deoxy-D-xylulose 5- geneity by a combination of EDTA/lysozyme treatment phosphate synthase (Dxs).8) The two intermediates are and five chromatography steps. Gel-filtration chroma- then combined by PdxA and PdxJ proteins to generate 0 tography with Sephacryl S-200 and SDS/PAGE dem- the first vitamin B6 compound: pyridoxine 5 -phosphate onstrated that the protein was a monomer with a (PNP).9) PNP is finally oxidized to the active form, PLP, molecular size of approximately 29 kDa. The protein by a PNP/PMP oxidase (PdxH).10) PLP and PMP are required divalent metal ions for pyridoxine 50-phos- easily interconverted by ubiquitous transaminases. phate phosphatase activity, and specifically catalyzed Sinorhizobium (formerly known as Rhizobium) meli- the removal of Pi from pyridoxine and pyridoxal 50- loti IFO 14782 produces large quantities of PN.11) Since phosphates at physiological pH (about 7.5). It was two compounds, 1-deoxy-D-xylulose (1-DX) and 4- inactive on pyridoxamine 50-phosphate and other phys- hydroxy-L-theronine (4-HT), have been found to act as iologically important phosphorylated compounds. The precursors of PN in a study of the biosynthetic pathway 12) enzyme had the same Michaelis constant (Km) of 385 M of vitamin B6 we examined the biosynthesis of PN for pyridoxine and pyridoxal 50-phosphates, but its from 1-DX and 4-HT in vitro,13) and purified the specific constant [maximum velocity ðVmaxÞ=Km] was enzymes involved in its synthesis from the two nearly 2.5 times higher for the former than for the precursors (M. Tazoe, K. Ichikawa, and T. Hoshino, latter. unpublished results). BLAST searches of the five purified enzymes required for the formation of PN from Key words: phosphatase; pyridoxine 50-phosphate phos- the two compounds identified two putative xylulose phatase; vitamin B6; pyridoxine; Sinorhi- and homoserine kinases, 4-phosphohydroxy-L-threonine zobium (Rhizobium) meliloti dehydrogenase (PdxA), PNP synthase (PdxJ), and a conserved hypothetical protein, based on analysis of When pyridoxine (PN), which is also known as the chromosome sequence of S. meliloti strain 1021.14) vitamin B6***, and other compounds in this family are This suggests that PN is formed in the following taken up by living organisms, they are converted into sequence of reactions (Fig. 2): Initially, 1-DX and 4- 0 0 pyridoxal 5 -phosphate (PLP) and pyridoxamine 5 - HT are converted to 1-deoxy-D-xylulose 5-phosphate 15) phosphate (PMP). These act as cofactors of vitamin B6 and 4-phosphohydroxy-L-threonine by xylulose kinase enzymes that are active in the metabolism of amino and homoserine kinase16,17) respectively. The latter acids1,2) and deoxysugars.3) Many microorganisms (bac- product is then oxidized by PdxA, followed by con- teria, yeasts, fungi, and algae) and plants synthesize their densation with 1-deoxy-D-xylulose 5-phosphate by a own vitamin B6. The biosynthetic pathway in Esche- PdxJ protein to yield PNP, as it is in E. coli. The final richia coli is well understood (Fig. 1). It contains two step requires a hypothetical protein that dephospho- key intermediates, 4-phosphohydroxy-L-threonine and rylates PNP to PN and an enzyme with the required y To whom correspondence should be addressed. Tel/Fax: +81-42-739-8682; E-mail: [email protected] * Present address: Mycology and Metabolic Diversity Research Center, Tamagawa University Research Institute, Machida, Tokyo 194-8610, Japan ** Present address: Research Planning and Coordination Department, Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan Abbreviations: 1-DX, 1-deoxy-D-xylulose; 4-HT, 4-hydroxy-L-threonine; p-NPP, p-nitrophenylphosphate; PLP, pyridoxal 50-phosphate; PMP, pyridoxamine 50-phosphate; PN, pyridoxine; PNP, pyridoxine 50-phosphate 0 *** In this paper, the term vitamin B6 is used to denote the six compounds, pyridoxine, pyridoxal, pyridoxamine, and their 5 -phosphate esters. 2278 M. TAZOE et al. Fig. 1. Currently Proposed Biosynthetic Pathway for Vitamin B6 in Escherichia coli. Materials and Methods Materials. ATP, ADP, AMP, malate, and phospho-L- serine were purchased from Wako Pure Chemical (Osaka, Japan). PN, PLP, PMP, p-nitrophenylphosphate (p-NPP), and most of the other biochemicals were obtained from Sigma Chemical (St. Louis, MO.). PNP was synthesized by reducing PLP with sodium borohy- dride according to the method of Stock et al.18) Most of the chromatographic media and prepacked columns were purchased from Amersham Biosciences (Uppsala, Sweden), and Ether Toyopearl was purchased from Toyo Soda Manufacturing (Tokyo). All other chemicals were of reagent grade and were purchased from commercial sources. Microorganisms, media, and cell growth. S. meliloti Fig. 2. Proposed Pathway for Pyridoxine from 1-Deoxy-D-xylulose IFO 14782 was cultured in a Pi-rich production medium and 4-Hydroxy-L-threonine in S. meliloti. composed of 4% glucose, 2% polypeptone, 0.2% yeast extract, 0.05% MgSO4.7H2O, 0.05% MnSO4.5H2O, properties, which is the subject of this paper. In and 0.001% FeSO4.7H2O (pH 6.8) at 28 C. The vitamin B6 biosynthesis in microorganisms, an enzyme Pi-limited chemically defined medium for the induction catalyzing dephosphorylation of PNP has not yet been of periplasmic marker proteins comprised the following: identified. With a view to understanding the dephos- 1% glucose and L-arginine, glycine, L-histidine, L- phorylation step in the biosynthesis of PN in S. meliloti isoleucine, L-leucine, L-lysine, L-methionine, L-threo- and our ultimate aim of gene engineering PN produc- nine, L-valine, L-aspartic acid, L-glutamic acid, L- tion, it is important to characterize the enzyme catalyz- phenylalanine, and L-tyrosine; pantothenic acid, inositol, ing the dephosphorylation of PNP. Here we show that nicotinic acid, thiamine, and biotin; and MnSO4.5H2O, this enzyme is a cytoplasmic PNP/PLP-specific phos- MgSO4.7H2O, CaCl2.2H2O, KCl, and KH2PO4, which phatase that is active as a monomer at physiological pH. was limited to 14 mg/l (pH 7.0). Sinorhizobium Pyridoxine 50-Phosphate Phosphatase 2279 Fractionation of cellular proteins. S. meliloti IFO dephosphorylase. The cell cake (59.5 g) formed by 14782 was grown in the production medium for 3 d. centrifugation of a 3-d culture broth (3.4-liter) in After harvesting by centrifugation, the cells were production medium was washed twice with 300 ml of subcultured in the chemically defined medium and in 0.85% NaCl and resuspended in 340 ml of buffer A. The the production medium for an additional 6 h. Then they cellular proteins were divided into periplasmic and were pelleted, washed twice with 0.85% NaCl, and cytoplasmic fractions using the procedure described suspended in buffer A [30 mM Tris–HCl (pH 8.0) con- above. taining 20% (w/v) sucrose and 1 mM EDTA]. Then Step 2. Q Sepharose column chromatography (I). The lysozyme (0.05%, w/v) was added at 23 C with slow lysate of the cytoplasmic fraction was centrifuged, and stirring for 20 min, and the suspensions were separated the supernatant was dialyzed against buffer B and into periplasmic proteins and cell pellets by centrifuga- applied to a Q Sepharose column (4:4 Â 17 cm). It was tion. The periplasmic fractions were dialyzed against developed with 600 ml of 400 mM KCl at a flow rate of buffer B [10 mM Tris–HCl (pH 7.5) containing 15% 0.57 ml/min. (w/v) sucrose, 1 mM dithiothreitol, and 0.1 mM phenyl- Step 3. Q Sepharose column rechromatography (II). methylsulfonyl fluoride], and alkaline phosphatase ac- The active fractions, which were dialyzed against tivity was measured by recording the hydrolysis of p- buffer B, were then applied to a Q Sepharose column NPP.19) The activity from the Pi-limited culture was (4:4 Â 12:5 cm). Elution was carried out at a flow rate of 1.56 mmol/min/mg protein, and that from the Pi-rich 0.72 ml/min with a linear gradient of KCl (0–400 mM)in culture was about 36-fold lower. When the cytoplasmic buffer B (total volume, 2,200 ml). marker enzyme malate dehydrogenase was assayed by Step 4. Ether Toyopearl column chromatography. The 20) monitoring the rate of oxidation of NADH (A340), no sample was dialyzed against buffer B and adjusted to activity was found in the periplasmic fractions of either 1.3 M (NH4)2SO4, and then applied to an Ether Toyo- culture. pearl column (2:5 Â 15 cm) previously equilibrated with To obtain the cytoplasmic proteins, pelleted cells buffer B containing 1.3 M (NH4)2SO4. Elution was were resuspended in buffer B and passed through a carried out at a flow rate of 0.7 ml/min with a linear French pressure cell, and the suspensions were centri- gradient of (NH4)2SO4 (1.3–0.5 M) in buffer B (total fuged at 37;500 Â g for 1 h. Cytoplasmic extracts of both volume, 1,000 ml).
Recommended publications
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall Et Al
    USOO9689046B2 (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall et al. (45) Date of Patent: Jun. 27, 2017 (54) SYSTEM AND METHODS FOR THE FOREIGN PATENT DOCUMENTS DETECTION OF MULTIPLE CHEMICAL WO O125472 A1 4/2001 COMPOUNDS WO O169245 A2 9, 2001 (71) Applicants: Robert Matthew Mayall, Calgary (CA); Emily Candice Hicks, Calgary OTHER PUBLICATIONS (CA); Margaret Mary-Flora Bebeselea, A. et al., “Electrochemical Degradation and Determina Renaud-Young, Calgary (CA); David tion of 4-Nitrophenol Using Multiple Pulsed Amperometry at Christopher Lloyd, Calgary (CA); Lisa Graphite Based Electrodes', Chem. Bull. “Politehnica” Univ. Kara Oberding, Calgary (CA); Iain (Timisoara), vol. 53(67), 1-2, 2008. Fraser Scotney George, Calgary (CA) Ben-Yoav. H. et al., “A whole cell electrochemical biosensor for water genotoxicity bio-detection”. Electrochimica Acta, 2009, 54(25), 6113-6118. (72) Inventors: Robert Matthew Mayall, Calgary Biran, I. et al., “On-line monitoring of gene expression'. Microbi (CA); Emily Candice Hicks, Calgary ology (Reading, England), 1999, 145 (Pt 8), 2129-2133. (CA); Margaret Mary-Flora Da Silva, P.S. et al., “Electrochemical Behavior of Hydroquinone Renaud-Young, Calgary (CA); David and Catechol at a Silsesquioxane-Modified Carbon Paste Elec trode'. J. Braz. Chem. Soc., vol. 24, No. 4, 695-699, 2013. Christopher Lloyd, Calgary (CA); Lisa Enache, T. A. & Oliveira-Brett, A. M., "Phenol and Para-Substituted Kara Oberding, Calgary (CA); Iain Phenols Electrochemical Oxidation Pathways”, Journal of Fraser Scotney George, Calgary (CA) Electroanalytical Chemistry, 2011, 1-35. Etesami, M. et al., “Electrooxidation of hydroquinone on simply prepared Au-Pt bimetallic nanoparticles'. Science China, Chem (73) Assignee: FREDSENSE TECHNOLOGIES istry, vol.
    [Show full text]
  • Paraneoplastic Neurological and Muscular Syndromes
    Paraneoplastic neurological and muscular syndromes Short compendium Version 4.5, April 2016 By Finn E. Somnier, M.D., D.Sc. (Med.), copyright ® Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark 30/01/2016, Copyright, Finn E. Somnier, MD., D.S. (Med.) Table of contents PARANEOPLASTIC NEUROLOGICAL SYNDROMES .................................................... 4 DEFINITION, SPECIAL FEATURES, IMMUNE MECHANISMS ................................................................ 4 SHORT INTRODUCTION TO THE IMMUNE SYSTEM .................................................. 7 DIAGNOSTIC STRATEGY ..................................................................................................... 12 THERAPEUTIC CONSIDERATIONS .................................................................................. 18 SYNDROMES OF THE CENTRAL NERVOUS SYSTEM ................................................ 22 MORVAN’S FIBRILLARY CHOREA ................................................................................................ 22 PARANEOPLASTIC CEREBELLAR DEGENERATION (PCD) ...................................................... 24 Anti-Hu syndrome .................................................................................................................. 25 Anti-Yo syndrome ................................................................................................................... 26 Anti-CV2 / CRMP5 syndrome ............................................................................................
    [Show full text]
  • Disorders Affecting Vitamin B6 Metabolism
    Received: 8 October 2018 Accepted: 12 December 2018 DOI: 10.1002/jimd.12060 REVIEW Disorders affecting vitamin B6 metabolism Matthew P. Wilson1 | Barbara Plecko2 | Philippa B. Mills1 | Peter T. Clayton1 1Genetics and Genomic Medicine, UCL GOS Institute of Child Health, London, UK Abstract 0 2Department of Pediatrics and Adolescent Vitamin B6 is present in our diet in many forms, however, only pyridoxal 5 -phosphate Medicine, Division of General Pediatrics, (PLP) can function as a cofactor for enzymes. The intestine absorbs nonphosphorylated University Childrens' Hospital Graz, B vitamers, which are converted by specific enzymes to the active PLP form. The role Medical University Graz, Graz, Austria 6 of PLP is enabled by its reactive aldehyde group. Pathways reliant on PLP include Correspondence amino acid and neurotransmitter metabolism, folate and 1-carbon metabolism, protein Philippa B. Mills, Genetics and Genomic and polyamine synthesis, carbohydrate and lipid metabolism, mitochondrial function Medicine, UCL GOS Institute of Child Health, 30 Guilford Street, London WC1N and erythropoiesis. Besides the role of PLP as a cofactor B6 vitamers also play other 1EH, UK. cellular roles, for example, as antioxidants, modifying expression and action of steroid Email: [email protected] Communicating Editor: Slyvia Stockler- hormone receptors, affecting immune function, as chaperones and as an antagonist of Ipsiroglu Adenosine-5'-triphosphate (ATP) at P2 purinoceptors. Because of the vital role of PLP in neurotransmitter metabolism, particularly synthesis of the inhibitory transmitter Funding information γ Schweizerischer Nationalfonds zur -aminobutyric acid, it is not surprising that various inborn errors leading to PLP defi- Förderung der wissenschaftlichen Forschung ciency manifest as B6-responsive epilepsy, usually of early onset.
    [Show full text]
  • Supplementary Informations SI2. Supplementary Table 1
    Supplementary Informations SI2. Supplementary Table 1. M9, soil, and rhizosphere media composition. LB in Compound Name Exchange Reaction LB in soil LBin M9 rhizosphere H2O EX_cpd00001_e0 -15 -15 -10 O2 EX_cpd00007_e0 -15 -15 -10 Phosphate EX_cpd00009_e0 -15 -15 -10 CO2 EX_cpd00011_e0 -15 -15 0 Ammonia EX_cpd00013_e0 -7.5 -7.5 -10 L-glutamate EX_cpd00023_e0 0 -0.0283302 0 D-glucose EX_cpd00027_e0 -0.61972444 -0.04098397 0 Mn2 EX_cpd00030_e0 -15 -15 -10 Glycine EX_cpd00033_e0 -0.0068175 -0.00693094 0 Zn2 EX_cpd00034_e0 -15 -15 -10 L-alanine EX_cpd00035_e0 -0.02780553 -0.00823049 0 Succinate EX_cpd00036_e0 -0.0056245 -0.12240603 0 L-lysine EX_cpd00039_e0 0 -10 0 L-aspartate EX_cpd00041_e0 0 -0.03205557 0 Sulfate EX_cpd00048_e0 -15 -15 -10 L-arginine EX_cpd00051_e0 -0.0068175 -0.00948672 0 L-serine EX_cpd00054_e0 0 -0.01004986 0 Cu2+ EX_cpd00058_e0 -15 -15 -10 Ca2+ EX_cpd00063_e0 -15 -100 -10 L-ornithine EX_cpd00064_e0 -0.0068175 -0.00831712 0 H+ EX_cpd00067_e0 -15 -15 -10 L-tyrosine EX_cpd00069_e0 -0.0068175 -0.00233919 0 Sucrose EX_cpd00076_e0 0 -0.02049199 0 L-cysteine EX_cpd00084_e0 -0.0068175 0 0 Cl- EX_cpd00099_e0 -15 -15 -10 Glycerol EX_cpd00100_e0 0 0 -10 Biotin EX_cpd00104_e0 -15 -15 0 D-ribose EX_cpd00105_e0 -0.01862144 0 0 L-leucine EX_cpd00107_e0 -0.03596182 -0.00303228 0 D-galactose EX_cpd00108_e0 -0.25290619 -0.18317325 0 L-histidine EX_cpd00119_e0 -0.0068175 -0.00506825 0 L-proline EX_cpd00129_e0 -0.01102953 0 0 L-malate EX_cpd00130_e0 -0.03649016 -0.79413596 0 D-mannose EX_cpd00138_e0 -0.2540567 -0.05436649 0 Co2 EX_cpd00149_e0
    [Show full text]
  • The Quest for Novel Extracellular Polymers Produced by Soil-Borne Bacteria
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. Bioprospecting: The quest for novel extracellular polymers produced by soil-borne bacteria A thesis presented in partial fulfilment of the requirements for the degree of Master of Science In Microbiology at Massey University, Palmerston North, New Zealand Jason Smith 2017 i Dedication This thesis is dedicated to my dad. Vaughan Peter Francis Smith 13 July 1955 – 27 April 2002 Though our time together was short you are never far from my mind nor my heart. ii Abstract Bacteria are ubiquitous in nature, and the surrounding environment. Bacterially produced extracellular polymers, and proteins are of particular value in the fields of medicine, food, science, and industry. Soil is an extremely rich source of bacteria with over 100 million per gram of soil, many of which produce extracellular polymers. Approximately 90% of soil-borne bacteria are yet to be cultured and classified. Here we employed an exploratory approach and culture based method for the isolation of soil-borne bacteria, and assessed their capability for extracellular polymer production. Bacteria that produced mucoid (of a mucous nature) colonies were selected for identification, imaging, and polymer production. Here we characterised three bacterial isolates that produced extracellular polymers, with a focus on one isolate that formed potentially novel proteinaceous cell surface appendages. These appendages have an unknown function, however, I suggest they may be important for bacterial communication, signalling, and nutrient transfer.
    [Show full text]
  • Effects of Vitamin B6 Metabolism on Oncogenesis, Tumor Progression and Therapeutic Responses
    Oncogene (2013) 32, 4995–5004 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc REVIEW Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses L Galluzzi1,2,8, E Vacchelli2,3,4, J Michels2,3,4, P Garcia2,3,4, O Kepp2,3,4, L Senovilla2,3,4, I Vitale2,3,4 and G Kroemer1,4,5,6,7,8 Pyridoxal-50-phosphate (PLP), the bioactive form of vitamin B6, reportedly functions as a prosthetic group for 44% of classified enzymatic activities of the cell. It is therefore not surprising that alterations of vitamin B6 metabolism have been associated with multiple human diseases. As a striking example, mutations in the gene coding for antiquitin, an evolutionary old aldehyde dehydrogenase, result in pyridoxine-dependent seizures, owing to the accumulation of a metabolic intermediate that inactivates PLP. In addition, PLP is required for the catabolism of homocysteine by transsulfuration. Hence, reduced circulating levels of B6 vitamers (including PLP as well as its major precursor pyridoxine) are frequently paralleled by hyperhomocysteinemia, a condition that has been associated with an increased risk for multiple cardiovascular diseases. During the past 30 years, an intense wave of clinical investigation has attempted to dissect the putative links between vitamin B6 and cancer. Thus, high circulating levels of vitamin B6, as such or as they reflected reduced amounts of circulating homocysteine, have been associated with improved disease outcome in patients bearing a wide range of hematological and solid neoplasms. More recently, the proficiency of vitamin B6 metabolism has been shown to modulate the adaptive response of tumor cells to a plethora of physical and chemical stress conditions.
    [Show full text]
  • Supplementary Figure 1. Pyridoxine Deficiency Has No Effects on Total
    Supplementary Figure 1. Pyridoxine deficiency has no effects on total exploratory activity in control and Pyr-def mice; data were analyzed with two-way ANOVA followed by Bonferroni post-tests (n = 7 per group). 1 Fig. 1. Pyridoxine deficiency (Pyr-def) decreases serum and brain PLP levels, novel object recognition memory, and monoamine levels in the hippocampus. (A) PLP concentration in serum and brain regions (cerebral cortex, hippocampus and thalamus); data are analyzed with the Student’s t-test (n = 20 per group; *p < 0.05). (B) Exploration time for familiar and new objects and the discrimination index in control and Pyr-def mice; data were analyzed with two-way ANOVA followed by Bonferroni post-tests (n = 7 per group; *p < 0.05, significant difference between familiar and new object, #p < 0.05, significant difference between control and pyr-def group) and Student’s t-test (n = 7 per group; *p < 0.05). (C) 5- Hydroxytryptamine (5-HT), its metabolite (5-HIAA), and ratio (5-HIAA/5-HT) in the hippocampus of control and Pyr-def mice measured with HPLC analysis (n = 7 mice per group; *P < 0.05). (D) Levels of 3,4-Dihydroxyphenethylamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and ratio (DOPAC/DA and HVA/DA) in the hippocampus of control and Pyr-def mice measured through HPLC analysis (n = 7 mice per group; *P < 0.05). 3.4. Effects of pyridoxine deficiency on Ki67 and DCX immunoreactivity In the control and Pyr-def groups, Ki67-positive proliferating cells were found in the subgranular zone of the dentate gyrus.
    [Show full text]
  • Investigating Vitamin B6-Dependent Epileptic Encephalopathies in Human Patients and a Mouse Model
    INVESTIGATING VITAMIN B6-DEPENDENT EPILEPTIC ENCEPHALOPATHIES IN HUMAN PATIENTS AND A MOUSE MODEL by Hilal Hamed Al Shekaili BSc, Sultan Qaboos University, 2008 MSc, Sultan Qaboos University, 2011 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in The Faculty of Graduate and Postdoctoral Studies (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) August 2020 © Hilal Hamed Al Shekaili, 2020 The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: Investigating Vitamin B6-Dependent Epileptic Encephalopathies in Human Patients and a Mouse Model submitted by Hilal Al Shekaili in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Medical Genetics Examining Committee: Dr. Jan M. Friedman, Department of Medical Genetics Supervisor Dr. Blair R. Leavitt, Department of Medical Genetics Co-supervisor Dr. Lorne Clarke, Department of Medical Genetics Supervisory Committee Member Dr. Sylvia Stockler, Department of Pediatrics University Examiner Dr. Daniel Goldowitz, Department of Medical Genetics University Examiner Additional Supervisory Committee Members: Dr. William T. Gibson, Department of Medical Genetics Supervisory Committee Member Dr. Clara van Karnebeek, Department of Pediatrics Supervisory Committee Member ii Abstract PLPHP deficiency is a recently discovered form of vitamin B6-dependent epilepsies (B6Es) that is caused by recessive mutations in PLPBP. PLPHP is involved in pyridoxal 5’-phosphate (PLP) homeostatic regulation. However, the mechanism by which PLPHP dysfunction disrupts PLP homeostasis and leads to the observed encephalopathy in patients was still elusive. We characterized the clinical, genomic and biochemical abnormalities in a new series of 12 PLPHP deficiency patients.
    [Show full text]
  • Vitamin B-6 Metabolism and Interactions with TNAP Stephen P
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Opus: Research and Creativity at IPFW Indiana University - Purdue University Fort Wayne Opus: Research & Creativity at IPFW Chemistry Faculty Publications Department of Chemistry 2015 Vitamin B-6 Metabolism and Interactions with TNAP Stephen P. Coburn Indiana University - Purdue University Fort Wayne, [email protected] This research is a product of the Department of Chemistry faculty at Indiana University-Purdue University Fort Wayne. Follow this and additional works at: http://opus.ipfw.edu/chemistry_facpubs Part of the Biochemistry Commons, and the Chemistry Commons Opus Citation Stephen P. Coburn (2015). Vitamin B-6 Metabolism and Interactions with TNAP. Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP). 207-238. London: Springer. http://opus.ipfw.edu/chemistry_facpubs/96 This Book Chapter is brought to you for free and open access by the Department of Chemistry at Opus: Research & Creativity at IPFW. It has been accepted for inclusion in Chemistry Faculty Publications by an authorized administrator of Opus: Research & Creativity at IPFW. For more information, please contact [email protected]. Chapter 11 Vitamin B-6 Metabolism and Interactions with TNAP Stephen P. Coburn Abstract Two observations stimulated the interest in vitamin B-6 and alkaline phosphatase in brain: the marked increase in plasma pyridoxal phosphate and the occurrence of pyridoxine responsive seizures in hypophosphatasia. The increase in plasma pyridoxal phosphate indicates the importance of tissue non-specific alkaline phosphatase (TNAP) in transferring vitamin B-6 into the tissues. Vitamin B-6 is involved in the biosynthesis of most of the neurotransmitters.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • Characterization of Cell Biological and Physiological Functions of the Phosphoglycolate Phosphatase AUM
    Characterization of cell biological and physiological functions of the phosphoglycolate phosphatase AUM Charakterisierung zellbiologischer und physiologischer Funktionen der Phosphoglykolat-Phosphatase AUM Dissertation for a doctoral degree at the Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg (Section Biomedicine) submitted by Gabriela Segerer from Kitzingen am Main Würzburg, November 2015 Submitted on: ……………………………………………………………… Members of the Promotionskomitee : Chairperson: Prof. Dr. Manfred Gessler Primary Supervisor: Prof. Dr. Antje Gohla Supervisor (Second): Prof. Dr. Dr. Manfred Schartl Supervisor (Third): PD Dr. Heike Hermanns Date of Public Defence: …………………………………………… Date of Receipt of Certificates: …………………………………………. Table of contents Table of contents 1 INTRODUCTION 1 1.1 Phospho-regulation by kinases and phosphatases 1 1.2 Classification of phosphatases 2 1.3 Haloacid dehalogenase (HAD) phosphatases 3 1.3.1 Structural features of HAD phosphatases 3 1.3.2 HAD phosphatases in health and diseases 5 1.4 Characterization of phosphoglycolate phosphatase PGP 6 1.4.1 PGP dephosphorylates phosphoglycolate in vitro 7 1.4.1.1 Source of mammalian phosphoglycolate (PG) 7 1.4.1.2 Function of mammalian phosphoglycolate (PG) 8 1.4.1.3 TPI controls a branch point between glucose- and lipid metabolism 10 1.4.2 PGP acts as a tyrosine-directed phosphatase in vitro 11 1.4.3 PGP is a regulator of integrin-dependent cell adhesion 13 1.5 Integrins 14 1.5.1 Integrin signaling 15 1.5.2 Integrin-dependent cell adhesion, spreading
    [Show full text]